Evidence map›Paper›PMID 41031141›Full record

ArticleOne health (Amsterdam, Netherlands)2025

Seroepidemiological surveillance of neutralizing antibodies against dengue virus serotypes among healthy adults in Bangkok, Thailand.

Jakkraphong Nindee, Peeraya Ekchariyawat, Nichamon Pingkul, Wanwimon Thananate, Kedsara Panyasu, Thawisup Bunyamali, Pichayapa Penwichit, Chunya Puttikhunt, Sutha Sangiambut, Jiraphan Junjhon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jakkraphong NindeeDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Peeraya EkchariyawatDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Nichamon PingkulDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Wanwimon ThananateDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Kedsara PanyasuDepartment of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Thawisup BunyamaliDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Pichayapa PenwichitDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.
Chunya PuttikhuntMolecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum-thani, 12120, Thailand.
Sutha SangiambutMolecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum-thani, 12120, Thailand.
Jiraphan JunjhonDepartment of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bangkok is a hyper-endemic urban area for dengue virus (DENV), where ongoing transmission poses a significant public health risk. Comprehensively understanding the interplay between human immunity, vector ecology, and environmental determinants is essential for developing effective, sustainable dengue control strategies. Population-level immunity provides insights into prior dengue exposure, and the presence of neutralizing antibody may reflect protection against infection. While most previous studies have focused on children, serological data on adults, who constitute the majority of those with continuous exposure, remain limited. This study aimed to characterize neutralizing antibody responses to all four DENV serotypes among healthy adults residing in Bangkok. Residual serum samples from 198 healthy adults collected in 2022 were analyzed, with equal distribution of males and females across five age groups. Neutralizing antibody responses against parental DENV-1 to DENV-4 were assessed using the focus reduction neutralization test (FRNT), with seropositivity defined as an FRNT

Indexed as

BangkokDengue surveillanceDengue virusMosquito-borne diseasesNeutralizing antibodySeroepidemiology

Identifiers

PMID41031141
PMCPMC12478061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.